EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study

Sizheng Steven Zhao iD, Kimme Hyrich, Zenas Yiu, Anne Barton, John Bowes

Arthritis & Rheumatology · 2024

DOI: 10.1002/art.42942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Sizheng Steven Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom. Hauptthemen laut MEDLINE: Interleukin-13, Mendelian Randomization Analysis, Psoriasis, Arthritis, Psoriatic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Inhibitors of the interleukin 13 (IL‐13) pathway, such as dupilumab, are licensed for atopic dermatitis and asthma. Adverse events resembling psoriatic disease after dupilumab initiation have been reported, but evidence is limited to case reports with uncertain causality. We aimed to investigate whether genetically mimicked IL‐13 inhibition (IL‐13i) is associated with risk of psoriatic arthritis (PsA) and psoriasis.

Methods

We instrumented IL‐13i using a protein‐coding variant in the IL13 gene, rs20541, that is associated with circulating eosinophil count (biomarker of IL‐13i) at genome‐wide significance in a study of 563,946 individuals. Outcome genetic data were taken from studies of PsA, psoriasis, and related spondyloarthritis traits in up to 10,588 cases and 209,287 controls. Colocalization analysis was performed to examine genetic confounding. We additionally used circulating IgE as a biomarker to test whether associations were replicated, both in the test and in an independent genetic dataset. We also replicated analyses using individual‐level data from the UK Biobank.

Results

Genetically proxied IL‐13i was associated with increased risk of PsA (odds ratio [OR] 37.39; 95% confidence interval [95% CI] 11.52–121.34; P = 1.64 × 10 −9 ) and psoriasis (OR 20.08; 95% CI 4.38–92.01; P = 1.12 × 10 −4 ). No consistent associations were found for Crohn disease, ulcerative colitis, ankylosing spondylitis, or iritis. Colocalization showed no strong evidence of genetic confounding for psoriatic disease. Results were replicated using circulating IgE for the exposure, using independent outcome data and using individual‐level data.

Conclusion

We provide supportive genetic evidence that IL‐13i is linked to increased risk of PsA and psoriasis. Physicians prescribing IL‐13 inhibitors should be vigilant for these adverse events. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-13Mendelian Randomization AnalysisPsoriasisArthritis, PsoriaticHumansPolymorphism, Single NucleotideGenetic Predisposition to DiseaseImmunoglobulin EMaleFemale

Substanzen

Interleukin-13IL13 protein, humanImmunoglobulin E

Autor:innen und Institutionen

  • Centre for Musculoskeletal Research, The University of Manchester, Manchester, United Kingdom.
  • Centre for Musculoskeletal Research and NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, United Kingdom.
  • NIHR Manchester Biomedical Research Centre and Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom.

ORCID-Profile: Sizheng Steven Zhao

Zitieren

APA

Zhao, S. S., Hyrich, K., Yiu, Z., Barton, A., & Bowes, J. (2024). Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study. Arthritis & Rheumatology. https://doi.org/10.1002/art.42942

Vancouver

Zhao SS, Hyrich K, Yiu Z, Barton A, Bowes J. Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study. Arthritis & Rheumatology. 2024. doi:10.1002/art.42942

BibTeX
@article{Zhao2024,
  author = {Zhao, Sizheng Steven and Hyrich, Kimme and Yiu, Zenas and Barton, Anne and Bowes, John},
  title = {Genetically Proxied Interleukin‐13 Inhibition Is Associated With Risk of Psoriatic Disease: A Mendelian Randomization Study},
  journal = {Arthritis & Rheumatology},
  year = {2024},
  doi = {10.1002/art.42942}
}
Kostenlos starten →